Back to search

Article

Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysis

2022-01-18

Abstract excerpt

<h4>Background: </h4> In the diagnostic work-up of deep vein thrombosis (DVT), the use of point-of-care-test (POCT) D-dimer assays is emerging as a promising patient-friendly alternative to regular D-dimer assays, but their cost-effectiveness is unknown. We compared the cost-effectiveness of two POCT-based approaches to the most common, laboratory-based, situation. Methods A patient-level simulation model was dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86aebd24-2150-527b-8307-8111fc51fb00
DOI
10.21203/rs.3.rs-1160342/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysisDOI 10.21203/rs.3.rs-1160342/v1
Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.Semantic proximity
Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations.Semantic proximity
Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis.Semantic proximity
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra StudySemantic proximity
Development of a point-of-care genetic test for effective treatment of ischaemic stroke: an early model-based cost-effectiveness analysisSemantic proximity
Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.Semantic proximity
New Oral Anticoagulants Versus Low Molecular Weight Heparins for the Treatment of Cancer-associated Thrombosis: a Cost-effectiveness AnalysisSemantic proximity
Peri-Procedural Healthcare Costs of Thromboembolic and Bleeding Events in Patients on Direct Oral Anticoagulants Undergoing High-Risk EndoscopySemantic proximity
Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.Semantic proximity
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling outcomes and cost effectivenessSemantic proximity
Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis.Semantic proximity
An eConsultant versus a hospital-based outpatient consultation for general (internal) medicine: a costing analysisSemantic proximity
Select a neighboring publication to make it the new centre.